Added to YB: 2023-08-04
Pitch date: 2023-08-04
RYTM:US [bullish]
Rhythm Pharmaceuticals, Inc.
+254.07%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally.
Market Cap
$6.0B
Pitch Price
$24.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
-30.53
P/E
-28.12
EV/Sales
30.68
Sector
Biotechnology
Category
N/A
Show full summary:
Rhythm Pharmaceuticals, Inc. RYTM:US
A summary for this pitch has not been created yet.
Read full article (0 min)